Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Korean scientists identify serum biomarkers of preeclampsia

Oct. 20, 2011

Brazilian university designs new analgesic with in vivo activity

Oct. 20, 2011

Phase II study assessed combination therapy containing rilotumumab in cancer

Oct. 20, 2011

Vandetanib/bicalutamide combination trial does not meet primary endpoint

Oct. 20, 2011

Exparel leads to sustained release of bupivacaine

Oct. 20, 2011

Analyses focus on cardiovascular risk with naltrexone/bupropion

Oct. 19, 2011

U.S. universities assess CDME in model of cystinuria

Oct. 19, 2011

Orantinib advances through studies in NSCLC and breast cancer

Oct. 19, 2011

Trial determines phase II doses of ixabepilone/cisplatin combination regimen in NSCLC

Oct. 19, 2011

Interim first-in-human data released on two c-Met inhibitors

Oct. 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...